CFDE Data Portal | Search NPY1R

	Label	Description
	NPY1R Gene (Entity type)	ENSG00000164128 - neuropeptide Y receptor Y1
	NPY1R associations Collection (Entity type)	Associations for NPY1R_associations
	NPY1R associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 1 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 11 V 6 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE146687 2 V 5 ERIBULIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 5 V 10 PREDNISOLONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125782 3 V 1 GLUTAMINE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

NPY1R

ENSG00000164128 - neuropeptide Y receptor Y1

NPY1R associations

Associations for NPY1R_associations

NPY1R associations.tsv

A file from IDG as part of the Harmonizome project

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human up

A Gene Set from LINCS

GSE239844 crizotinib 1 v 10 human dn

A Gene Set from LINCS

GSE48812 11 V 6 SULFORAPHANE HUMAN DN

A Gene Set from LINCS

GSE146687 2 V 5 ERIBULIN HUMAN DN

A Gene Set from LINCS

GSE164874 5 V 10 PREDNISOLONE HUMAN DN

A Gene Set from LINCS

GSE125782 3 V 1 GLUTAMINE MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.